This year’s Scancell AGM was held on Tuesday 18th October at the Kassam Stadium (Home to Oxford United FC) which is adjacent to the Oxford Science park.
For Investors who are unfamiliar with the company, Scancell (SCLP) are an Aim listed Biopharmaceutical company specialising in developing vaccines for treatment of various types of cancer. The current market cap is approximately £50m with the shares at around 16p/share
Links to the annual report and AGM resolutions are here:
Annual Report: http://www.scancell.co.uk/investors/financial-info
AGM Resolutions: http://www.scancell.co.uk/investors/company-docs
Link to meeting ...